- Home
- BHVN vs ECAT Comparison
BHVN vs ECAT Comparison
Compare BHVN & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHVN | ECAT |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BHVN | ECAT |
|---|---|---|
| Price | $9.43 | $15.33 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.08 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 479.6K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $13.36 |
| 52 Week High | $18.57 | $17.14 |
Technical Indicators
Market Signals| Indicator | BHVN | ECAT |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 69.60 |
| Support Level | $9.26 | $14.92 |
| Resistance Level | $10.22 | $15.67 |
| Average True Range (ATR) | 0.71 | 0.18 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 19.55 | 97.91 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
About ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.